Follow Us:
Login
Register
Logout
My Profile
My Courses
Courses
Series
Specialties
Hematology/Oncology
Primary Care
Neurology
Cardiology
Psychiatric Medicine
Asthma & Allergies
Events
COVID-19
Home
» Reducing the Risk of MACE in T2DM with GLP-1RAs: Real World Considerations to Personalize Therapy
Reducing the Risk of MACE in T2DM with GLP-1RAs: Real World Considerations to Personalize Therapy
CME: 0.75
January 28, 2021
No Comments
Email
/
Print
/
Reprints
/
|
More
/
Text Size+
Larger
Smaller
[X]
Related Articles
Recognition and Treatment of HeFH in Real World Practice, A Nationwide Survey of Cardiologists & Primary Care Physicians
Source:
https://www.freecme.com/ACHL/diabetesseries
Post a comment to this article
Name
*
E-mail
(will not be displayed)
*
Subject
Comment
*
Report Abusive Comment
Thank you for helping us to improve our forums. Is this comment offensive? Please tell us why.
More